Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Clobazam for Epilepsia Partialis Continua
NCT02134366Phase 3Terminated
- Sponsor
- Cooper University Health Care
- Start
- Jul 2014
- Primary completion
- Jul 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of clobazam in epilepsia partialis continua (EPC), sponsored by Cooper University Health Care. Started Jul 2014; status: terminated.
02
Drugs
clobazam
03
Conditions
epilepsia partialis continua (EPC)
Beyond the preview
Go deeper on NCT02134366.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02134366.